Cargando…

Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))

BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) need comprehensive, interdisciplinary and cross-sectoral health care. In Germany, evidence-based care pathways have been developed to improve the quality of care of IBD patients. We aimed to evaluate the effects of the implementation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Langbrandtner, Jana, Hüppe, Angelika, Jessen, Petra, Büning, Jürgen, Nikolaus, Susanna, Raspe, Heiner, Bokemeyer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590680/
https://www.ncbi.nlm.nih.gov/pubmed/28919797
http://dx.doi.org/10.2147/CEG.S135346
_version_ 1783262568385609728
author Langbrandtner, Jana
Hüppe, Angelika
Jessen, Petra
Büning, Jürgen
Nikolaus, Susanna
Raspe, Heiner
Bokemeyer, Bernd
author_facet Langbrandtner, Jana
Hüppe, Angelika
Jessen, Petra
Büning, Jürgen
Nikolaus, Susanna
Raspe, Heiner
Bokemeyer, Bernd
author_sort Langbrandtner, Jana
collection PubMed
description BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) need comprehensive, interdisciplinary and cross-sectoral health care. In Germany, evidence-based care pathways have been developed to improve the quality of care of IBD patients. We aimed to evaluate the effects of the implementation of some of these recommendations on patient-related outcomes. METHODS: In a region of North Germany, outpatients with IBD were recruited by gastroenterologists (intervention group). Three activities based on the recommendations of the IBD pathways were implemented, namely, 1) patient participation in a questionnaire-based assessment of 22 somatic and psychosocial problems combined with individualized care recommendations (patient activation procedure); 2) patient invitation to participate in a 2-day patient education program and 3) invitation to their gastroenterologists to participate in periodic interdisciplinary case conferences. For the control group, IBD patients receiving standard care at gastroenterology practices outside the specified region were recruited by their doctors. At baseline, 6- and 12-month follow-up, study patients were invited to complete questionnaires. Generic health-related quality of life, social participation and self-management skills were the main outcomes. RESULTS: At baseline, 349 patients were included in the study (intervention group: 189; control group: 160); 142 patients from the former and 140 from the latter group returned completed questionnaires at the 12-month follow-up. Over time, improvement in health-related quality of life and social participation was similar in both groups. Participants of the intervention group demonstrated improved self-management skills and more often followed steroid-free medication regimens. CONCLUSION: In a real-world clinical context, patient activation procedure combined with patient education and case conferences was less effective than expected. The observed beneficial effects, however, encourage the evaluation of more intensive and addressee-centered activities.
format Online
Article
Text
id pubmed-5590680
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55906802017-09-15 Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD)) Langbrandtner, Jana Hüppe, Angelika Jessen, Petra Büning, Jürgen Nikolaus, Susanna Raspe, Heiner Bokemeyer, Bernd Clin Exp Gastroenterol Original Research BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) need comprehensive, interdisciplinary and cross-sectoral health care. In Germany, evidence-based care pathways have been developed to improve the quality of care of IBD patients. We aimed to evaluate the effects of the implementation of some of these recommendations on patient-related outcomes. METHODS: In a region of North Germany, outpatients with IBD were recruited by gastroenterologists (intervention group). Three activities based on the recommendations of the IBD pathways were implemented, namely, 1) patient participation in a questionnaire-based assessment of 22 somatic and psychosocial problems combined with individualized care recommendations (patient activation procedure); 2) patient invitation to participate in a 2-day patient education program and 3) invitation to their gastroenterologists to participate in periodic interdisciplinary case conferences. For the control group, IBD patients receiving standard care at gastroenterology practices outside the specified region were recruited by their doctors. At baseline, 6- and 12-month follow-up, study patients were invited to complete questionnaires. Generic health-related quality of life, social participation and self-management skills were the main outcomes. RESULTS: At baseline, 349 patients were included in the study (intervention group: 189; control group: 160); 142 patients from the former and 140 from the latter group returned completed questionnaires at the 12-month follow-up. Over time, improvement in health-related quality of life and social participation was similar in both groups. Participants of the intervention group demonstrated improved self-management skills and more often followed steroid-free medication regimens. CONCLUSION: In a real-world clinical context, patient activation procedure combined with patient education and case conferences was less effective than expected. The observed beneficial effects, however, encourage the evaluation of more intensive and addressee-centered activities. Dove Medical Press 2017-09-04 /pmc/articles/PMC5590680/ /pubmed/28919797 http://dx.doi.org/10.2147/CEG.S135346 Text en © 2017 Langbrandtner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Langbrandtner, Jana
Hüppe, Angelika
Jessen, Petra
Büning, Jürgen
Nikolaus, Susanna
Raspe, Heiner
Bokemeyer, Bernd
Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title_full Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title_fullStr Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title_full_unstemmed Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title_short Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NET(IBD))
title_sort quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in germany (net(ibd))
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590680/
https://www.ncbi.nlm.nih.gov/pubmed/28919797
http://dx.doi.org/10.2147/CEG.S135346
work_keys_str_mv AT langbrandtnerjana qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT huppeangelika qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT jessenpetra qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT buningjurgen qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT nikolaussusanna qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT raspeheiner qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd
AT bokemeyerbernd qualityofcareininflammatoryboweldiseaseresultsofaprospectivecontrolledcohortstudyingermanynetibd